Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion L Snyder

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 16, 2010
Quantification of busulfan in plasma using liquid chromatography electrospray tandem mass spectrometry (HPLC-ESI-MS/MS)Marion L Snyder, James C Ritchie
Clinical Chemistry|July 31, 2008
Cirrhosis originally diagnosed as nonalcoholic steatohepatitisMarion L Snyder, Corinne R Fantz
The Journal of Applied Laboratory Medicine|February 27, 2021
Setting Up and Overseeing Mass Spectrometry-Based Labs in Physician Offices and Other Non-Traditional Sites (PMSI)Marion L Snyder, Emily L Ryan
Clinical Chemistry|November 30, 2014
Drug addiction or false conviction?Marion L Snyder, Stacy E F Melanson
Pain Physician|February 23, 2017
Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic PainMarion L Snyder, Corrine R Fantz, Stacy Melanson
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2011
A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl complianceMarion L Snyder, Petr Jarolim, Stacy E F Melanson
Clinical Chemistry|August 13, 2010
Patient misidentifications caused by errors in standard bar code technologyMarion L Snyder, Alexis Carter, Karen Jenkins, et al.
Pain Physician|July 24, 2014
KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic painAlicia Darragh, Marion L Snyder, Adam S Ptolemy, et al.
Genes|November 27, 2024
Gene Variant Frequencies of <i>IDO1</i>, <i>IDO2</i>, <i>TDO</i>, and <i>KMO</i> in Substance Use Disorder CohortsLindsey Contella, Christopher L Farrell, Luigi Boccuto, et al.
Journal of Analytical Toxicology|March 16, 2012
A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuseStacy E F Melanson, Marion L Snyder, Petr Jarolim, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|January 16, 2010
Quantification of busulfan in plasma using liquid chromatography electrospray tandem mass spectrometry (HPLC-ESI-MS/MS)Marion L Snyder, James C Ritchie
Clinical Chemistry|July 31, 2008
Cirrhosis originally diagnosed as nonalcoholic steatohepatitisMarion L Snyder, Corinne R Fantz
The Journal of Applied Laboratory Medicine|February 27, 2021
Setting Up and Overseeing Mass Spectrometry-Based Labs in Physician Offices and Other Non-Traditional Sites (PMSI)Marion L Snyder, Emily L Ryan
Clinical Chemistry|November 30, 2014
Drug addiction or false conviction?Marion L Snyder, Stacy E F Melanson
Pain Physician|February 23, 2017
Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic PainMarion L Snyder, Corrine R Fantz, Stacy Melanson
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2011
A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl complianceMarion L Snyder, Petr Jarolim, Stacy E F Melanson
Clinical Chemistry|August 13, 2010
Patient misidentifications caused by errors in standard bar code technologyMarion L Snyder, Alexis Carter, Karen Jenkins, et al.
Pain Physician|July 24, 2014
KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic painAlicia Darragh, Marion L Snyder, Adam S Ptolemy, et al.
Genes|November 27, 2024
Gene Variant Frequencies of <i>IDO1</i>, <i>IDO2</i>, <i>TDO</i>, and <i>KMO</i> in Substance Use Disorder CohortsLindsey Contella, Christopher L Farrell, Luigi Boccuto, et al.
Journal of Analytical Toxicology|March 16, 2012
A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuseStacy E F Melanson, Marion L Snyder, Petr Jarolim, et al.
Pageof 2